(Q78640385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

A Gratwohl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

H Baldomero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

A Urbano-Ispizua

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

European Group for Blood and Marrow Transplantation (EBMT). Accreditation Committee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

15 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

813-831

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12476273%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703819

15 December 2019

exact match

0 references

cites work

Stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Is there an upper age limit for bone marrow transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Immunotherapy of cancer with alloreactive lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Non-myeloablative stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Hematopoietic allogeneic transplantation with attenuated conditioning regimen on an outpatient basis. First experience in Spain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Transplantation in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Stem cell transplant numbers decline; research continues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

High-dose chemotherapy and autologous stem cell transplantation for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021

Autologous cord blood transplantation. A procedure with potential beyond bone marrow replacement?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703819

7 January 2021